Using evidence and being open-minded are 2 strategies for providers shifting to new models of delivering care, says Lee A. Norman, MD, MHS, MBA, senior medical director for Optum Care Kansas City.
Using evidence and being open-minded are 2 strategies for providers shifting to new models of delivering care, says Lee A. Norman, MD, MHS, MBA, senior medical director for Optum Care Kansas City.
Transcript
What role can physicians play in driving innovation and leadership in health care, particularly when it comes to adopting new models of care?
The role of physicians in how to lead in a value-based care world is one that I think we really have to be creative and innovative, because we need better and stronger models for care. Physicians should be open-minded to looking at new and challenging different ways to do things. Sometimes it means, as I said earlier, using evidence to change our practices, because there are certain things, quite honestly, that don't work. And yet they're very traditionally implemented. And we see lots of those specifically, in neurologic situations. A lot of cardiac, a lot of excess imaging is done, that doesn't really have a payback in terms of the clinical quality.
And then finally, clinical quality indicators. The data is getting more robust all the time, and we need to pay attention to outcomes, and especially where there is disparities and outcomes, we have to understand why. B physicians can lead by being creative and innovative, and it's really important to be open-minded.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Semaglutide Shows Promise for MASH Resolution, Severe Fibrosis: Naim Alkhouri, MD
May 9th 2025Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis (MASH) and severe fibrosis.
Read More